top
Search terms
Results 1 - 3 of 3 - ordered by :
Ehjournal

Introduction Proprotein convertase subtilisin kexin 9 (PCSK9) has received considerable attention in the last decade as a promising target for lipid-lowering therapy.1,2 Proprotein convertase ...

European Heart Journal, Gencer, Baris, Montecucco, Fabrizio, Nanchen, David, Carbone, Federico, Klingenberg, Roland, Vuilleumier, Nicolas, Aghlmandi, Soheila, Heg, Dik, Räber, Lorenz, Auer, Reto, ...

Date : 07/02/2016 Item size : 359297 bytes
Ehjournal

Controversy only exists as to whether LDL cholesterol target levels or risk-adjusted dosing should be used in their management,5 with the former advocated by the European Society of Cardiology and ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/02/2015
Ehjournal

Controversy only exists as to whether LDL cholesterol target levels or risk-adjusted dosing should be used in their management,5 with the former advocated by the European Society of Cardiology and ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/02/2015 Item size : 197952 bytes